Mgenplus Co.,Ltd. announced a private placement of 1,800,000 common shares at an issue price of KRW 1,000 per share for gross proceeds of KRW 1,800,000,000 on July 26, 2021. The par value of shares is KRW 500. The transaction will include participation from returning investor Transgene Bio Co., Ltd. The shares will be issued pursuant to 3rd party allocation increase method.

The payment date of the transaction is August 3, 2021. The transaction is approved by board of directors of the company. The shares are subject to a hold period of one year.